Scientific Posters

  • Fezagepras (PBI-4050) A Free Fatty Acid Mimetic for the Treatment of NAFLD

    Fezagepras (PBI-4050) A Free Fatty Acid Mimetic for the Treatment of NAFLD

    Read PDF
  • Fezagepras (PBI-4050) Reduces Pulmonary Fibroblast Activation

    Fezagepras (PBI-4050) Reduces Pulmonary Fibroblast Activation

    Read PDF
  • Fezagepras (PBI-4050) reverses metabolic dysregulation induced by a high fat diet

    Fezagepras (PBI-4050) reverses metabolic dysregulation induced by a high fat diet

    Read PDF
  • Fezagepras (PBI-4050) reduces angio-proliferative pulmonary arterial hypertension

    Fezagepras (PBI-4050) reduces angio-proliferative pulmonary arterial hypertension

    Read PDF

  • More PBI-4050 posters

    Learn More
  • Fatty Acid Receptors GPR40/GPR84: Two Promising Targets in Kidney Fibrosis

    Fatty Acid Receptors GPR40/GPR84: Two Promising Targets in Kidney Fibrosis

    Read PDF
  • Activation of the Free-fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease Via a Novel EPO-Independent Mechanism of

    Activation of the Free-fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease Via a Novel EPO-Independent Mechanism of

    Read PDF
  • Activation of the Free-Fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease via a Novel EPO-Independent Mechanism of

    Activation of the Free-Fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease via a Novel EPO-Independent Mechanism of

    Read PDF

  • More GPR40/GPR84 posters

    Learn More
  • PBI-4547 Restores Metabolic Homeostasis in a High Fat Diet Model of Non-Alcoholic Fatty Liver Disease

    PBI-4547 Restores Metabolic Homeostasis in a High Fat Diet Model of Non-Alcoholic Fatty Liver Disease

    Read PDF
  • PBI-4547 Reverses Diabetes and Metabolic Syndrome through Regulation of Lipid/Glucose Metabolism, -Oxidation and Fibrosis in Liver and Whit

    PBI-4547 Reverses Diabetes and Metabolic Syndrome through Regulation of Lipid/Glucose Metabolism, -Oxidation and Fibrosis in Liver and Whit

    Read PDF
  • ×

    Get the updates before everyone else.

    First Name
    Last Name
    * By completing and submitting this form, you understand and agree that use of Liminal BioSciences' web site is subject to Liminal BioSciences Privacy Policy
    !
    Thank you!
    Error - something went wrong!
  • PBI-4547 Prevents Progression of Prediabetic Condition to Type 1 Diabetes in NOD Mice

    PBI-4547 Prevents Progression of Prediabetic Condition to Type 1 Diabetes in NOD Mice

    Read PDF
  • PBI-4547 Improves Glucose Metabolism and Insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of Obesity and Metaboli

    PBI-4547 Improves Glucose Metabolism and Insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of Obesity and Metaboli

    Read PDF

  • More PBI-4547 posters

    Learn More
  • loading
    Loading More...